osilodrostat side effects

Osilodrostat is a drug used to treat Cushing's disease. It mainly reduces cortisol levels in the body by inhibiting the synthesis of adrenocortical hormones (such as cortisol), thereby alleviating related symptoms caused by excess cortisol. Although oxidrostat has shown certain efficacy in clinical treatment, its side effects also require special attention.

1.Common side effects

Headache: Patients may experience mild to moderate headache while taking oxidrostat, especially during the early stages of treatment.

Nausea and Vomiting: Nausea and vomiting are common adverse reactions due to the potential irritation of the gastrointestinal tract. In most cases these symptoms are temporary and will subside as the body adjusts to the medication.

Diarrhea or constipation: Oxidrostat may also cause gastrointestinal disorders, including diarrhea or constipation. Patients should closely monitor their digestive system response and communicate with their doctor to adjust their treatment plan.

2.Serious side effects

Adrenal Crisis (Adrenal Crisis): By inhibiting the production of cortisol, oxidrostat may lead to a sudden decline in adrenal function and the risk of adrenal crisis, especially hormone fluctuations that occur after improper dosage adjustment or discontinuation of the drug. Such situations may cause severe symptoms such as acute hypoglycemia, hypotension, and dehydration, requiring timely medical intervention.

Hypokalemia (Hypokalemia): Oxidrostat may cause a decrease in serum potassium levels, resulting in hypokalemia. Hypokalemia can manifest as muscle weakness, irregular heartbeat and other symptoms, and may be life-threatening in severe cases. Regular monitoring of electrolyte levels is important for patients taking this medication.

Heart problems: Some patients may develop heart-related problems such as palpitations, irregular heartbeats, or changes in blood pressure after taking the drug, especially in patients with underlying cardiovascular disease.

3.Side effects of long-term use

Decreased bone density: Long-term use of oxidrostat may have effects on bone health, leading to a decrease in bone density and an increased risk of fractures. Such side effects usually need to be evaluated with regular bone density tests.

Psychological effects: A small number of patients may experience psychological reactions such as mood swings, depression or anxiety symptoms. Changes in cortisol levels may have certain effects on the nervous system, so the patient's mental health needs to be paid attention to during treatment.

Reference materials:https://isturisa.com/patient/